Can a new IV drug shrink advanced solid tumors?
Disease control
Not yet recruiting
This trial tests an experimental drug called RT023, given by infusion, in adults with advanced solid tumors that have not responded to standard treatments. The study has two main goals: first, to find the safest dose and check for side effects, and second, to see whether RT023 ca…
Phase 1/2 • Sponsor: Shanghai Ruotuo Biosciences Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC